{"ticker": {"uuid": "8c39be3c-58f9-4ccf-929b-076efa920f85", "symbol": "VKING", "name": "Viking Kagit ve Sel\u00fcloz A.S.", "exchange": "IST", "country": "TR", "sector": "Consumer Defensive", "industry": "Household & Personal Products"}, "articles": [{"title": "VKTX Stock Has Nearly 300% Wall Street Upside \u2014 Is Viking\u2019s Oral Obesity Pill The Next Novo Nordisk-Style Breakout?", "summary": "", "url": "https://news.google.com/rss/articles/CBMi3gFBVV95cUxQNzR3UDloSVJaalp4cXFKdWFzeVNrRU5hTkZzRTZza3hhWXg3MGJVejM0OEUwbzlGSzZMRkVKOEhQREpPQ2FWcFMzdUp6WkRqMnFoWVNBMzcyRjFycmRvZHFBUjRUMDZNX2stQ2RxbkZpYkszalN6S3BiWTJqclpTLWlTWmZFT1plNWxKTEhpaUF5aUtSQmxPMWtJbTk5MkVvdVc0ODRyOHdVQzMyTmV4cFh2b09vVVVFRVdCRDliRXFGamJCZmJhR3c1RDFPWDhRUGd1aXFJZWNqWnNMRWc?oc=5", "source_name": "Stocktwits", "published_at": "2026-06-21T08:45:40+00:00", "published_display": "21 Jun 2026 08:45", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Viking, Bloom Energy Lead Five Stocks Making Bullish Moves As Market Rebounds", "summary": "", "url": "https://news.google.com/rss/articles/CBMidEFVX3lxTFBqNzRCRHR0MHNjYTRickFUSDc3VWViaDFoYy11MmtHLWJkcWlPOWJMRkw3a3RKc3dWU2NHeS1STWZaVDBTaGVIemF6Q25TWXlsVnZxdzQ0Y1BZUWF4YVhSS1RPcW1jcDZVT2VEZmFKYU9WaG5C?oc=5", "source_name": "Investor's Business Daily", "published_at": "2026-06-13T07:00:00+00:00", "published_display": "13 Jun 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Is Viking Therapeutics Stock Going to $100?", "summary": "", "url": "https://news.google.com/rss/articles/CBMihAFBVV95cUxNVS1mVTJyN0ZZOHhucC0wcGtnRnBxWEtQQUhHQzJzN1FZdUFIakRON0c3eks2WnRTMG80VEZOaDlEcXlMY1hVbzJoRHVJZThkT2E5cHJaeWZGWl9hU3kxTHFtVFpkOXdMRzNZUWdSQ29lZVE1a3d6LWN6S2VLUE4tYW81UVM?oc=5", "source_name": "The Motley Fool", "published_at": "2026-06-12T07:00:00+00:00", "published_display": "12 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Vail Resorts vs. Viking Cruises: Which Travel Stock Is a Better Buy in 2026?", "summary": "", "url": "https://news.google.com/rss/articles/CBMixAFBVV95cUxQR25Jd3JsX0pJYUdEWmI2WWlWTVNOcGVVcF9tc1dod0ZBeVM4eFB1cDhVMVFBT09YSFlLdjlQc1BmTEJUS1hKdURuYlNweDI1dXVXMy1TallDQVRCZ1lRc09JUF9IWGY5aXMxWWtNRHVteWRoT1RJeWFkblZsaElBMTJsOVhJRDJaNzlGZV9xSHNCMXQzNWNWbEhQMTRUMHlySnVza282Z1JKNXN6WG1HS3dDcUJFd2owTEFzdW5PVGoyNlJj?oc=5", "source_name": "The Motley Fool", "published_at": "2026-06-11T07:00:00+00:00", "published_display": "11 Jun 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Why 1 Wall Street Analyst Thinks Viking Therapeutics Stock Could Soar 188%", "summary": "", "url": "https://news.google.com/rss/articles/CBMilAFBVV95cUxOWGRyUjVxS0diOUxRQjBsdHo4bzVfZDJ0LUdTNHpfYUUtTzg3YlNLYmFLVWM4QVFVdVFqMENzQlhGZklmQjl4Vnk5SlZ5bjBWX016Rnd5bkRxczR3TTE5bUZtMWtxWUxKbGl1OERrV3Fla2ExVEg2YzNYaEx4STJRY0dmc09CS1ZlZGFjbmJPWTZiTDgx?oc=5", "source_name": "The Motley Fool", "published_at": "2026-06-10T07:00:00+00:00", "published_display": "10 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "5 Reasons Viking Is a Different Kind of Cruise Line Stock", "summary": "", "url": "https://news.google.com/rss/articles/CBMimAFBVV95cUxOVjZtMmRtNVJobTQ1QktHelpRYjdReG94OGxWVXZhaExlTkZ1b0IzeWRGR0oxbk9vLWNhdmxaMktRN1otU2JNZUozcHdlN2c5aEMtdDl1cE15QzRSdEJiWGYyZWlGY0hyNmN1VjFzR2ctTU1kdEhuazEzWTZMR2hiVjYxcVJRX0M3aUJZZVFYWllFdk55WjVmOA?oc=5", "source_name": "The Motley Fool", "published_at": "2026-06-10T07:00:00+00:00", "published_display": "10 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Don't Buy Viking Therapeutics Stock Until You Read This", "summary": "", "url": "https://news.google.com/rss/articles/CBMijgFBVV95cUxNUTZXelQtZWdQTVJMaWNCNEFCOEYxdWhNZDAtVlZJemZiRTRzb3o5MURsc0lIZVFBZGdNdFhEY0Y1aENibVFqU3VfMUtjUEl3TmR3OTJLSFdKZmZ6NnhPNEJmX0ZheHdZbzlRVWQ3bnN4amlFQlB5NDl5eEl4SWl2MVB1dUo5aUw0UW1CSmhR?oc=5", "source_name": "The Motley Fool", "published_at": "2026-05-25T07:00:00+00:00", "published_display": "25 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Viking Therapeutics: InvestingPro\u2019s overvalued call proved prescient By Investing.com", "summary": "", "url": "https://news.google.com/rss/articles/CBMixgFBVV95cUxPdEVBc2NBQUNEb0ktNlB6aUFkVlROVm94RFpOWlp0dm9NZmsyOHlYOVlnNWRCUU9IaVdoT0gxa2Q4em5pMGp6Z1JZbFZHVnZNdFFOeTkyYXpKOWNZb1NaSVR4OTBMUnRwbDkydllZdkpJTnBhWm5YUzBpUkhsdG8tUExIZE91Z0hFOVpybDJuMjNKOXltV2prWS0zYkxCRExpS1VlQXpvV1JzTnpIUmNVcHVoTWRNdmFPc1cyLWt5ZENyV2hzV2c?oc=5", "source_name": "Investing.com", "published_at": "2026-05-04T07:00:00+00:00", "published_display": "04 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Why Viking Therapeutics (VKTX) Is Down 8.4% After Expanding VK2735 Phase 3 Obesity Program And Loss", "summary": "", "url": "https://news.google.com/rss/articles/CBMipAFBVV95cUxQWk1zazVuWG1pU000czU5RTBUa3ZUbTJIOGs2OVR0ZkdsWlgzZ1F5NWJ2elVYRHdvSV9MOEFqcUpkVmZydVhZckF6MXh4ZkxyLU84UDZheGllOW5pOU9iSVp5QlV0Ylp0VXF4a1lNMG9zU0htZ3JGbGZaX3NzNFptZWtxLWsxQ2VYaUtCUHpuN1l6MW1rZkpDaEZPYTlXNkNaN0hLTg?oc=5", "source_name": "Market source", "published_at": "2026-05-02T07:00:00+00:00", "published_display": "02 May 2026 07:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Assessing Viking Therapeutics (VKTX) Valuation As Obesity Trial Optimism Meets Richer Balance Sheet Ratios", "summary": "", "url": "https://news.google.com/rss/articles/CBMirgFBVV95cUxQZ1ZMakFxRmxtRk16WS0tTllOenZiSWk1Y1JRX09nTG9uTG5QaFFtcmxxTHFMd01yUkxlLXNoYUxPRG4zSHNNbTUyeS1SWGJxUllzV3pzUWR4cVgybFdQUXpvNC0tb0p3Um9ldmg5cS1odndiR2tUZU1tODI0YXpTeWxHQjY1YTNCb2xMTWQ3SUdlaFFoem1QS3lURHY0Wjc2cV90UVRFbVN2NUlJbHc?oc=5", "source_name": "Market source", "published_at": "2026-04-20T07:00:00+00:00", "published_display": "20 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Strength Seen in Viking (VIK): Can Its 6.8% Jump Turn into More Strength?", "summary": "", "url": "https://news.google.com/rss/articles/CBMilgFBVV95cUxQM2FSMXg2akNaaWFGb3U1VmFfZU55MWJ2bVFxRm04Y0hWNUdyUU9ZXy1odzFWRWM1em1YeDRUeVdkY1ZLWW8xYVRQNm1xdFJjRVUzSVFwQ25LUWR1VG5OR0s2ZkRYWjhpLTRLck9jdTNrZ3hpNC1ia1kxMnVOQnE1dGsza2EzRW90eEduUGFzaW8ta09vbkE?oc=5", "source_name": "Market source", "published_at": "2026-04-20T07:00:00+00:00", "published_display": "20 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Better Long-Term Buy: Eli Lilly or Viking Therapeutics?", "summary": "", "url": "https://news.google.com/rss/articles/CBMimAFBVV95cUxNZW8yTWhtV1B3LWtMdE1Od2NuVGhoNUtlS3NzTkhPUWJ6dVNpeWN5NHFhdVVDajRBbTBBaXoxNHEzQ19jbUtCSGt2c1NCMEVhSFlNWVFWUzBJSEZkSU9qVHdoUmFMMmc4b0NJakllTnoyRm5jT3pfQ1pWSG44ZTZ2SzNuRlJkNUtXc28zUFZ6Wkh5aFMwdkFWSw?oc=5", "source_name": "Market source", "published_at": "2026-04-17T07:00:00+00:00", "published_display": "17 Apr 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Is Viking Therapeutics the Ultimate Millionaire-Maker Obesity Stock for 2026?", "summary": "", "url": "https://news.google.com/rss/articles/CBMitgFBVV95cUxPTkFYZlg1b2t6Q2oxM01SV2d4Vl9EcUNZcHVCUGpoRWhQX0M4Skp2SVh3eElTaEtJRkNsM3o1Q1Y5Mmp2WUdFZ1FaSFdJSG1XdWd4cWRZb3VJeGNDQkF6eVRBNkY0MFNNTVExWFp3MGwwSXd1WkdXa1dkSmZqTVV1d0pWT1NwSGYzZjJ5N3gzSEtrUl9abFNNR0JtQVAzck1TSUpjSDlMS0p5alpuLXFKYWFDNHZFdw?oc=5", "source_name": "Market source", "published_at": "2026-04-17T07:00:00+00:00", "published_display": "17 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Stock Of The Day Viking Outpaces Rivals, Near Buy Point", "summary": "", "url": "https://news.google.com/rss/articles/CBMivAFBVV95cUxOLWVKcUpNY2kwUVlCbUsxWUJXZTFGeTNUa3g3c2o2aExjUzJHX0FMd3JvdVZYNUc1Mk9vb3FQU3A0VE1uaHVySkxybVRfM01TZ3ViRGxiRnAzd2hCYTJTdWNzRm82MEZtUU9zTVlPRlpmN2Z6NWxGWUxOVDJ2cHk1TGNCVVNxd2ZhczI3RlA2YTlnMEl3bGRaakI3YVJVaS0yVzA4bV9mS1gyN1dWQXlqZFNBQzh3M0F4cU12UQ?oc=5", "source_name": "Investor's Business Daily", "published_at": "2026-04-16T07:00:00+00:00", "published_display": "16 Apr 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Why Viking Therapeutics Stock Could Take Off Later This Year", "summary": "", "url": "https://news.google.com/rss/articles/CBMimAFBVV95cUxNQlBId1ZoMDIxb1VlUUhSdkppWFlVNXNraG1JYzh3WmFkVDh2UjhDbU5uUVh6clNLbHlhM1BoZ1VKdV9RSXpSRTYydjVTNFM4Y05uOTRxTHBpcXcwTGZLVm5feVo1VWZWbjVjSEd3U09fVVktN0ZtVTZYMUYzQnFUbjVLVm5Od2ROSzJYbWFLcUl3RTI5THBtaQ?oc=5", "source_name": "The Motley Fool", "published_at": "2026-03-23T07:00:00+00:00", "published_display": "23 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Viking Therapeutics Stock Gets RS Rating Upgrade", "summary": "", "url": "https://news.google.com/rss/articles/CBMihwFBVV95cUxOVU9lbGxVTEVpLTJSXy1rZy1yRVRoQnEydDV5R0l4WkFFM3V6b2RLZ1hrdFdoZm55UmFQT3NkeWRGVXlabGFnV2dybzZ6NEFZVHlvV0FtSldxcktiLWpGa3JtNUJxQ2twNFJwYTdGS0VkTlEwQWVYSG5Nc29jbHhNSzAtOU5jV3c?oc=5", "source_name": "Investor's Business Daily", "published_at": "2026-03-10T07:00:00+00:00", "published_display": "10 Mar 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Why Viking Therapeutics Stock Is Up More Than 9% Today", "summary": "", "url": "https://news.google.com/rss/articles/CBMihwFBVV95cUxNekVuRDg0eThLcTVUWTh0OHI0ZUU4a0UzV1h0SjJsTUh5TnNQeW5xVkNKQ3VTT1Y5X0tkQWZfTjFQWHVhNEt6V1BrVVVQbHVqcFFEa0ExQk1KMm5HLXRTczZaSEwwOVlnVUNrR3FjNDc5YVFWWkV6Ynpsa0R2R0ZzUEJoekhIVDQ?oc=5", "source_name": "Market source", "published_at": "2026-02-23T08:00:00+00:00", "published_display": "23 Feb 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Is Viking Therapeutics Stock Really Going to $125?", "summary": "", "url": "https://news.google.com/rss/articles/CBMijAFBVV95cUxPUWFYRTVWUEVUcmJJMHdaSzlFel8xdHdzLXhuTEdaSTcwRzUtbmZWMy1hZUJJZFNIcG5remNyUDVkX04wU2lRRmhSekxmampFV1dQYlY3SlkyOTJKc3F5WTYtOGtqVlp1d1JTb2tpNlZpY1p0WUxyRmRBaXE3RnMwbHBrSTUxM0gtblhJTg?oc=5", "source_name": "Market source", "published_at": "2026-02-19T08:00:00+00:00", "published_display": "19 Feb 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Viking Therapeutics to Report Q4 Earnings: Here's What to Know", "summary": "", "url": "https://news.google.com/rss/articles/CBMijAFBVV95cUxON1F2Ymp6OWRVTUpBb1dyR3IyUjBjdzJxeGI0V19mXzNfWHZOVm1iVG5ISnJ1dWhBcGJ3ejNvSFhkdGtSdFBpR3FjckJPSUhVS09raVNWWEZxMHZpQkp5Z3ZGYlBGd25VRFB2TVZ2LWtyNVpINlM2WVRSNGNXTDhERktDb0xOYWRaenVtcQ?oc=5", "source_name": "Market source", "published_at": "2026-01-30T08:00:00+00:00", "published_display": "30 Jan 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Viking Therapeutics (VKTX) Valuation Check After Recent Share Price Weakness", "summary": "", "url": "https://news.google.com/rss/articles/CBMijwFBVV95cUxPRFJEOVkzZW85SVpVUnZiS25raUlxYl80Um0zZUVCaXhxZjJpcGJWSmxiNWZNbzZOUDVicG42RHY0RHRQcTJwNldjZFFlZlRVdHp4TzVuN2tjMTRuTmVULXc4SndJMVJKTEhVTmM3NXlxcnZmdlNmZG9QX1l2YllfVlZIalFzUUhoWTdHM0lJRQ?oc=5", "source_name": "Market source", "published_at": "2026-01-07T08:00:00+00:00", "published_display": "07 Jan 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "by_tier": {"direct": [{"title": "VKTX Stock Has Nearly 300% Wall Street Upside \u2014 Is Viking\u2019s Oral Obesity Pill The Next Novo Nordisk-Style Breakout?", "summary": "", "url": "https://news.google.com/rss/articles/CBMi3gFBVV95cUxQNzR3UDloSVJaalp4cXFKdWFzeVNrRU5hTkZzRTZza3hhWXg3MGJVejM0OEUwbzlGSzZMRkVKOEhQREpPQ2FWcFMzdUp6WkRqMnFoWVNBMzcyRjFycmRvZHFBUjRUMDZNX2stQ2RxbkZpYkszalN6S3BiWTJqclpTLWlTWmZFT1plNWxKTEhpaUF5aUtSQmxPMWtJbTk5MkVvdVc0ODRyOHdVQzMyTmV4cFh2b09vVVVFRVdCRDliRXFGamJCZmJhR3c1RDFPWDhRUGd1aXFJZWNqWnNMRWc?oc=5", "source_name": "Stocktwits", "published_at": "2026-06-21T08:45:40+00:00", "published_display": "21 Jun 2026 08:45", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Viking, Bloom Energy Lead Five Stocks Making Bullish Moves As Market Rebounds", "summary": "", "url": "https://news.google.com/rss/articles/CBMidEFVX3lxTFBqNzRCRHR0MHNjYTRickFUSDc3VWViaDFoYy11MmtHLWJkcWlPOWJMRkw3a3RKc3dWU2NHeS1STWZaVDBTaGVIemF6Q25TWXlsVnZxdzQ0Y1BZUWF4YVhSS1RPcW1jcDZVT2VEZmFKYU9WaG5C?oc=5", "source_name": "Investor's Business Daily", "published_at": "2026-06-13T07:00:00+00:00", "published_display": "13 Jun 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Is Viking Therapeutics Stock Going to $100?", "summary": "", "url": "https://news.google.com/rss/articles/CBMihAFBVV95cUxNVS1mVTJyN0ZZOHhucC0wcGtnRnBxWEtQQUhHQzJzN1FZdUFIakRON0c3eks2WnRTMG80VEZOaDlEcXlMY1hVbzJoRHVJZThkT2E5cHJaeWZGWl9hU3kxTHFtVFpkOXdMRzNZUWdSQ29lZVE1a3d6LWN6S2VLUE4tYW81UVM?oc=5", "source_name": "The Motley Fool", "published_at": "2026-06-12T07:00:00+00:00", "published_display": "12 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Vail Resorts vs. Viking Cruises: Which Travel Stock Is a Better Buy in 2026?", "summary": "", "url": "https://news.google.com/rss/articles/CBMixAFBVV95cUxQR25Jd3JsX0pJYUdEWmI2WWlWTVNOcGVVcF9tc1dod0ZBeVM4eFB1cDhVMVFBT09YSFlLdjlQc1BmTEJUS1hKdURuYlNweDI1dXVXMy1TallDQVRCZ1lRc09JUF9IWGY5aXMxWWtNRHVteWRoT1RJeWFkblZsaElBMTJsOVhJRDJaNzlGZV9xSHNCMXQzNWNWbEhQMTRUMHlySnVza282Z1JKNXN6WG1HS3dDcUJFd2owTEFzdW5PVGoyNlJj?oc=5", "source_name": "The Motley Fool", "published_at": "2026-06-11T07:00:00+00:00", "published_display": "11 Jun 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Why 1 Wall Street Analyst Thinks Viking Therapeutics Stock Could Soar 188%", "summary": "", "url": "https://news.google.com/rss/articles/CBMilAFBVV95cUxOWGRyUjVxS0diOUxRQjBsdHo4bzVfZDJ0LUdTNHpfYUUtTzg3YlNLYmFLVWM4QVFVdVFqMENzQlhGZklmQjl4Vnk5SlZ5bjBWX016Rnd5bkRxczR3TTE5bUZtMWtxWUxKbGl1OERrV3Fla2ExVEg2YzNYaEx4STJRY0dmc09CS1ZlZGFjbmJPWTZiTDgx?oc=5", "source_name": "The Motley Fool", "published_at": "2026-06-10T07:00:00+00:00", "published_display": "10 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "5 Reasons Viking Is a Different Kind of Cruise Line Stock", "summary": "", "url": "https://news.google.com/rss/articles/CBMimAFBVV95cUxOVjZtMmRtNVJobTQ1QktHelpRYjdReG94OGxWVXZhaExlTkZ1b0IzeWRGR0oxbk9vLWNhdmxaMktRN1otU2JNZUozcHdlN2c5aEMtdDl1cE15QzRSdEJiWGYyZWlGY0hyNmN1VjFzR2ctTU1kdEhuazEzWTZMR2hiVjYxcVJRX0M3aUJZZVFYWllFdk55WjVmOA?oc=5", "source_name": "The Motley Fool", "published_at": "2026-06-10T07:00:00+00:00", "published_display": "10 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Don't Buy Viking Therapeutics Stock Until You Read This", "summary": "", "url": "https://news.google.com/rss/articles/CBMijgFBVV95cUxNUTZXelQtZWdQTVJMaWNCNEFCOEYxdWhNZDAtVlZJemZiRTRzb3o5MURsc0lIZVFBZGdNdFhEY0Y1aENibVFqU3VfMUtjUEl3TmR3OTJLSFdKZmZ6NnhPNEJmX0ZheHdZbzlRVWQ3bnN4amlFQlB5NDl5eEl4SWl2MVB1dUo5aUw0UW1CSmhR?oc=5", "source_name": "The Motley Fool", "published_at": "2026-05-25T07:00:00+00:00", "published_display": "25 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Viking Therapeutics: InvestingPro\u2019s overvalued call proved prescient By Investing.com", "summary": "", "url": "https://news.google.com/rss/articles/CBMixgFBVV95cUxPdEVBc2NBQUNEb0ktNlB6aUFkVlROVm94RFpOWlp0dm9NZmsyOHlYOVlnNWRCUU9IaVdoT0gxa2Q4em5pMGp6Z1JZbFZHVnZNdFFOeTkyYXpKOWNZb1NaSVR4OTBMUnRwbDkydllZdkpJTnBhWm5YUzBpUkhsdG8tUExIZE91Z0hFOVpybDJuMjNKOXltV2prWS0zYkxCRExpS1VlQXpvV1JzTnpIUmNVcHVoTWRNdmFPc1cyLWt5ZENyV2hzV2c?oc=5", "source_name": "Investing.com", "published_at": "2026-05-04T07:00:00+00:00", "published_display": "04 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Why Viking Therapeutics (VKTX) Is Down 8.4% After Expanding VK2735 Phase 3 Obesity Program And Loss", "summary": "", "url": "https://news.google.com/rss/articles/CBMipAFBVV95cUxQWk1zazVuWG1pU000czU5RTBUa3ZUbTJIOGs2OVR0ZkdsWlgzZ1F5NWJ2elVYRHdvSV9MOEFqcUpkVmZydVhZckF6MXh4ZkxyLU84UDZheGllOW5pOU9iSVp5QlV0Ylp0VXF4a1lNMG9zU0htZ3JGbGZaX3NzNFptZWtxLWsxQ2VYaUtCUHpuN1l6MW1rZkpDaEZPYTlXNkNaN0hLTg?oc=5", "source_name": "Market source", "published_at": "2026-05-02T07:00:00+00:00", "published_display": "02 May 2026 07:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Assessing Viking Therapeutics (VKTX) Valuation As Obesity Trial Optimism Meets Richer Balance Sheet Ratios", "summary": "", "url": "https://news.google.com/rss/articles/CBMirgFBVV95cUxQZ1ZMakFxRmxtRk16WS0tTllOenZiSWk1Y1JRX09nTG9uTG5QaFFtcmxxTHFMd01yUkxlLXNoYUxPRG4zSHNNbTUyeS1SWGJxUllzV3pzUWR4cVgybFdQUXpvNC0tb0p3Um9ldmg5cS1odndiR2tUZU1tODI0YXpTeWxHQjY1YTNCb2xMTWQ3SUdlaFFoem1QS3lURHY0Wjc2cV90UVRFbVN2NUlJbHc?oc=5", "source_name": "Market source", "published_at": "2026-04-20T07:00:00+00:00", "published_display": "20 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Strength Seen in Viking (VIK): Can Its 6.8% Jump Turn into More Strength?", "summary": "", "url": "https://news.google.com/rss/articles/CBMilgFBVV95cUxQM2FSMXg2akNaaWFGb3U1VmFfZU55MWJ2bVFxRm04Y0hWNUdyUU9ZXy1odzFWRWM1em1YeDRUeVdkY1ZLWW8xYVRQNm1xdFJjRVUzSVFwQ25LUWR1VG5OR0s2ZkRYWjhpLTRLck9jdTNrZ3hpNC1ia1kxMnVOQnE1dGsza2EzRW90eEduUGFzaW8ta09vbkE?oc=5", "source_name": "Market source", "published_at": "2026-04-20T07:00:00+00:00", "published_display": "20 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Better Long-Term Buy: Eli Lilly or Viking Therapeutics?", "summary": "", "url": "https://news.google.com/rss/articles/CBMimAFBVV95cUxNZW8yTWhtV1B3LWtMdE1Od2NuVGhoNUtlS3NzTkhPUWJ6dVNpeWN5NHFhdVVDajRBbTBBaXoxNHEzQ19jbUtCSGt2c1NCMEVhSFlNWVFWUzBJSEZkSU9qVHdoUmFMMmc4b0NJakllTnoyRm5jT3pfQ1pWSG44ZTZ2SzNuRlJkNUtXc28zUFZ6Wkh5aFMwdkFWSw?oc=5", "source_name": "Market source", "published_at": "2026-04-17T07:00:00+00:00", "published_display": "17 Apr 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Is Viking Therapeutics the Ultimate Millionaire-Maker Obesity Stock for 2026?", "summary": "", "url": "https://news.google.com/rss/articles/CBMitgFBVV95cUxPTkFYZlg1b2t6Q2oxM01SV2d4Vl9EcUNZcHVCUGpoRWhQX0M4Skp2SVh3eElTaEtJRkNsM3o1Q1Y5Mmp2WUdFZ1FaSFdJSG1XdWd4cWRZb3VJeGNDQkF6eVRBNkY0MFNNTVExWFp3MGwwSXd1WkdXa1dkSmZqTVV1d0pWT1NwSGYzZjJ5N3gzSEtrUl9abFNNR0JtQVAzck1TSUpjSDlMS0p5alpuLXFKYWFDNHZFdw?oc=5", "source_name": "Market source", "published_at": "2026-04-17T07:00:00+00:00", "published_display": "17 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Stock Of The Day Viking Outpaces Rivals, Near Buy Point", "summary": "", "url": "https://news.google.com/rss/articles/CBMivAFBVV95cUxOLWVKcUpNY2kwUVlCbUsxWUJXZTFGeTNUa3g3c2o2aExjUzJHX0FMd3JvdVZYNUc1Mk9vb3FQU3A0VE1uaHVySkxybVRfM01TZ3ViRGxiRnAzd2hCYTJTdWNzRm82MEZtUU9zTVlPRlpmN2Z6NWxGWUxOVDJ2cHk1TGNCVVNxd2ZhczI3RlA2YTlnMEl3bGRaakI3YVJVaS0yVzA4bV9mS1gyN1dWQXlqZFNBQzh3M0F4cU12UQ?oc=5", "source_name": "Investor's Business Daily", "published_at": "2026-04-16T07:00:00+00:00", "published_display": "16 Apr 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Why Viking Therapeutics Stock Could Take Off Later This Year", "summary": "", "url": "https://news.google.com/rss/articles/CBMimAFBVV95cUxNQlBId1ZoMDIxb1VlUUhSdkppWFlVNXNraG1JYzh3WmFkVDh2UjhDbU5uUVh6clNLbHlhM1BoZ1VKdV9RSXpSRTYydjVTNFM4Y05uOTRxTHBpcXcwTGZLVm5feVo1VWZWbjVjSEd3U09fVVktN0ZtVTZYMUYzQnFUbjVLVm5Od2ROSzJYbWFLcUl3RTI5THBtaQ?oc=5", "source_name": "The Motley Fool", "published_at": "2026-03-23T07:00:00+00:00", "published_display": "23 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Viking Therapeutics Stock Gets RS Rating Upgrade", "summary": "", "url": "https://news.google.com/rss/articles/CBMihwFBVV95cUxOVU9lbGxVTEVpLTJSXy1rZy1yRVRoQnEydDV5R0l4WkFFM3V6b2RLZ1hrdFdoZm55UmFQT3NkeWRGVXlabGFnV2dybzZ6NEFZVHlvV0FtSldxcktiLWpGa3JtNUJxQ2twNFJwYTdGS0VkTlEwQWVYSG5Nc29jbHhNSzAtOU5jV3c?oc=5", "source_name": "Investor's Business Daily", "published_at": "2026-03-10T07:00:00+00:00", "published_display": "10 Mar 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Why Viking Therapeutics Stock Is Up More Than 9% Today", "summary": "", "url": "https://news.google.com/rss/articles/CBMihwFBVV95cUxNekVuRDg0eThLcTVUWTh0OHI0ZUU4a0UzV1h0SjJsTUh5TnNQeW5xVkNKQ3VTT1Y5X0tkQWZfTjFQWHVhNEt6V1BrVVVQbHVqcFFEa0ExQk1KMm5HLXRTczZaSEwwOVlnVUNrR3FjNDc5YVFWWkV6Ynpsa0R2R0ZzUEJoekhIVDQ?oc=5", "source_name": "Market source", "published_at": "2026-02-23T08:00:00+00:00", "published_display": "23 Feb 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Is Viking Therapeutics Stock Really Going to $125?", "summary": "", "url": "https://news.google.com/rss/articles/CBMijAFBVV95cUxPUWFYRTVWUEVUcmJJMHdaSzlFel8xdHdzLXhuTEdaSTcwRzUtbmZWMy1hZUJJZFNIcG5remNyUDVkX04wU2lRRmhSekxmampFV1dQYlY3SlkyOTJKc3F5WTYtOGtqVlp1d1JTb2tpNlZpY1p0WUxyRmRBaXE3RnMwbHBrSTUxM0gtblhJTg?oc=5", "source_name": "Market source", "published_at": "2026-02-19T08:00:00+00:00", "published_display": "19 Feb 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Viking Therapeutics to Report Q4 Earnings: Here's What to Know", "summary": "", "url": "https://news.google.com/rss/articles/CBMijAFBVV95cUxON1F2Ymp6OWRVTUpBb1dyR3IyUjBjdzJxeGI0V19mXzNfWHZOVm1iVG5ISnJ1dWhBcGJ3ejNvSFhkdGtSdFBpR3FjckJPSUhVS09raVNWWEZxMHZpQkp5Z3ZGYlBGd25VRFB2TVZ2LWtyNVpINlM2WVRSNGNXTDhERktDb0xOYWRaenVtcQ?oc=5", "source_name": "Market source", "published_at": "2026-01-30T08:00:00+00:00", "published_display": "30 Jan 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Viking Therapeutics (VKTX) Valuation Check After Recent Share Price Weakness", "summary": "", "url": "https://news.google.com/rss/articles/CBMijwFBVV95cUxPRFJEOVkzZW85SVpVUnZiS25raUlxYl80Um0zZUVCaXhxZjJpcGJWSmxiNWZNbzZOUDVicG42RHY0RHRQcTJwNldjZFFlZlRVdHp4TzVuN2tjMTRuTmVULXc4SndJMVJKTEhVTmM3NXlxcnZmdlNmZG9QX1l2YllfVlZIalFzUUhoWTdHM0lJRQ?oc=5", "source_name": "Market source", "published_at": "2026-01-07T08:00:00+00:00", "published_display": "07 Jan 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "industry": [], "sector": []}, "total_fetched": 70, "total_relevant": 20, "sentiment_summary": {"positive": 7, "negative": 1, "neutral": 12, "score": 56, "total": 20, "label": "Balanced news tone", "tone": "neutral"}, "classifier": {"primary_event": "general", "primary_label": "Market update", "confidence": 90, "events": [{"event": "general", "label": "Market update", "weight": 9.35, "count": 17}, {"event": "analyst", "label": "Analyst action", "weight": 1.1, "count": 2}, {"event": "earnings", "label": "Earnings", "weight": 0.55, "count": 1}], "positive_events": 7, "negative_events": 1}, "market_context": {"has_market_context": true, "latest_close": 25.28, "latest_week": "2026-06-19", "one_week_move": -1.2, "four_week_move": 1.0, "twelve_week_move": 7.6, "trend_signal": "0", "trend_label": "Trend inactive", "trend_tone": "negative", "market_dynamics": -0.025555, "market_dynamics_buy_signal": false, "relative_strength": -35.230863, "fair_value_gap": -24.3, "fair_value_label": "Below fair value", "fair_value_tone": "positive", "expectation_direction": "negative", "expectation_probability": 44.1245, "reaction_label": "Price digesting", "reaction_tone": "neutral", "market_sentence": "-1.2% over one week, +1.0% over four weeks, trend inactive, and below fair value."}, "interpretation": {"label": "Balanced read", "tone": "neutral", "classification": "balanced", "summary": "News tone and price action are not far from neutral.", "confidence": 69, "badges": ["Value support"], "opportunities": ["Price is below fair value while news tone is not negative."], "risks": [], "event_label": "Market update", "sentiment_word": "balanced"}, "charts": {"sources": [{"label": "Market source", "count": 9}, {"label": "The Motley Fool", "count": 6}, {"label": "Investor's Business Daily", "count": 3}, {"label": "Stocktwits", "count": 1}, {"label": "Investing.com", "count": 1}], "tiers": [{"label": "Direct company coverage", "count": 20}, {"label": "Industry context", "count": 0}, {"label": "Sector context", "count": 0}], "events": [{"label": "Market update", "count": 17}, {"label": "Analyst action", "count": 2}, {"label": "Earnings", "count": 1}]}, "insights": [{"label": "Weighted tone", "value": "56/100", "tone": "neutral", "text": "Balanced news tone"}, {"label": "Market reaction", "value": "Balanced read", "tone": "neutral", "text": "News tone and price action are not far from neutral."}, {"label": "Primary event", "value": "Market update", "tone": "neutral", "text": "90/100 classification confidence."}, {"label": "Company focus", "value": "20", "tone": "positive", "text": "directly relevant articles"}, {"label": "Source quality", "value": "0", "tone": "neutral", "text": "high-authority source matches"}, {"label": "Trend context", "value": "Trend inactive", "tone": "negative", "text": "-1.2% over one week, +1.0% over four weeks, trend inactive, and below fair value."}, {"label": "Latest direct headline", "value": "Positive", "tone": "positive", "text": "VKTX Stock Has Nearly 300% Wall Street Upside \u2014 Is Viking\u2019s Oral Obesity Pill The Next Novo Nordisk-Style Breakout?"}], "updated_at": "2026-06-23T04:36:56.394423+00:00", "disclaimer": "Educational market research only. Not financial, investment, trading, tax, or legal advice."}